HIGHLIGHTS
- who: Vilde Yuli Stenberg and colleagues from the Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Department of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway have published the research work: Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001, in the Journal: Cancers 2022, 14, 2784. of /2022/
- what: This study aimed to determine the influence of cellular PSMA expression binding and internalization and repeated administrations on the therapeutic effects of the PSMAtargeting 212 Cellular binding and internalization cytotoxicity biodistribution and the therapeutic efficacy of 212 were investigated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.